Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
Retatrutide Sexual Function Impact: What the Phase 2 Data Actually Show At a glance Drug / retatrutide (LY3437943), investigational triple GIP/GLP-1/glucagon receptor agonist Phase 2 trial / Jastreboff et al., NEJM 2023, N=338 adults with obesity Peak weight loss / 24.2% mean body-weight reduction at 48 weeks (12 mg dose) Sexual-function endpoints / not prespecified in Phase 2
That's enough to reap ample health benefits, like losing inches around your middle, which means less harmful visceral fat known as belly fat
That's a 111% increase in just one year
, ,
Understanding the Math: Concentration = Total Peptide (mg) Diluent Volume (mL) Volume per Dose = Desired Dose (mg) Concentration (mg/mL) Units = Volume (mL) 100 (for U-100 scale) Note: These are theoretical calculations for educational purposes
Your arms will be bigger in the triceps and biceps areas, which also removes any underarm and hanging fat
US$ 23.50
US$ 29.13
US$ 29.30
US$ 21.94
US$ 26.15
/sc-assets/prd/practices/cdcd65da-a892-465a-aa2c-48d5c1f8134f/Semaglutide%20vial.png)
US$ 28.78
